HPV Current Events | HPV News | 2
|
|
|
Sort By:
Page Views | Date |
HIV drug could be used to prevent cervical cancer, say University of Manchester researchers
Researchers at the University of Manchester are developing a topical treatment against the human papilloma virus (HPV) which is responsible for pre-cancerous and cancerous disease of the cervix as well as other genital malignancies. view more (2006-08-25)
HPV test is a better long-term predictor of cervical cell abnormalities than pap smear
The best initial cervical cancer screening tool for younger women is still the traditional Pap smear. However, a large Danish study has found that for older women (age 40 and older), a test for human papillomavirus (HPV) is a much more effective way to screen for potential cancer. view more (2006-11-01)
Few women have heard of virus associated with genital warts (HPV) and its link with cervical cancer
Few women have heard of the virus associated with genital warts (HPV), or are aware that it is linked to cervical cancer, reveals a study in Sexually Transmitted Infections. view more (2003-08-01)
Human Papillomavirus (HPV) Lesion Identified at the Dentist
Human papillomavirus (HPV) is a group of viruses that includes more than 100 different strains or types and is the most common sexually transmitted virus. view more (2009-02-19)
Girls born with HIV infection at higher risk for cervical problems
A generation of children born with HIV are now coming of age and reaching sexual maturity. Girls in this group who are sexually active are experiencing a higher number than expected of cervical abnormalities, a new study finds. view more (2007-04-27)
Response from Dr Peter Sasieni, senior scientist at Imperial Cancer Research Fund, in response to new research* that shows HPV is present in 99.7% of cervical cancers.
Response from Dr Peter Sasieni, senior scientist at Imperial Cancer Research Fund, in response to new research* that shows HPV is present in 99.7% of cervical cancers. view more (1999-08-25)
Study: HPV test beats Pap in detecting cervical cancer
A new study led by McGill University researchers shows that the human papillomavirus (HPV) screening test is far more accurate than the traditional Pap test in detecting cervical cancer. view more (2007-10-18)
Study shows continued success for new HPV vaccine against virus responsible for cervical cancer
A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer. view more (2007-05-10)
Temple University Hospital investigates treatment for cervical dysplasia
Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. view more (2007-01-31)
Research To Improve Screening For Warts Linked To Cervical Cancer Risk
Researchers are testing thousands of cervical smear samples to try and identify which types of wart viruses may lead to cancer. They will also examine the benefits of a new form of smear testing. Collaborating scientists and doctors from the University of Edinburgh, Lothian University Hospitals NHS Trust- and Lothian GPs- are creating a bank of... view more... (2002-04-24)
HPV vaccine does not appear to be effective for treating pre-existing HPV infection
For women with human papillomavirus (HPV) infection, use of the HPV-16/18 vaccine will not accelerate reduction of the virus and should not be used to treat the infection, according to a study in the August 15 issue of JAMA. view more (2007-08-15)
HPV testing could be future strategy for primary screening for cervical cancer (pp 1866, 1871)
Embargoed 0001 h (London time) 5 December 2003. Authors of a UK study in this week's issue of THE LANCET propose a new approach for cervical cancer screening. Testing for the human papilloma virus (HPV)-the main cause of cervical cancer-could be the primary screening tool, with cytology reserved for women who test positive for HPV. HPV testing... view more... (2003-12-03)
Self-collection of specimens for HPV testing
n this Research letter, Dr. Gina Ogilvie and colleagues investigate the feasibility of self-collection of specimens for HPV testing among women who may not make full use of cytology screening programs (e.g., women who are homeless or who are involved in the sex trade) and are thus at increased risk of cervical cancer. view more (2007-08-28)
Viruses may play a role in lung cancer development
Papers presented at the 1st European Lung Cancer Conference, jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight emerging evidence that common viruses may contribute to the development of lung cancer. view more (2008-04-25)
Cervical cancer screening: Too many are left unprotected
The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened. view more (2007-09-20)
A missed shot: The failure of HPV vaccination state requirements
In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrounding the human papillomavirus (HPV) vaccine debate, and its effects on ethical and public health issues. view more (2007-11-02)
Cervical cancer - a single vaccine could benefit most women
The risk of developing cervical cancer by women infected with the Human Papillomavirus (HPV) is essentially the same no matter which type of virus is involved, provided it belongs to the group of 15 or so that are currently identified as high risk, a scientist said today. view more (2003-09-20)
New study shows potential to treat or prevent viral cancers
A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy. view more (2008-06-17)
A New Startup Fund Called EMERTEC
CEA (the French Atomic Energy Commission) and the Caisse des Dépôts et Consignations (CDC) promoted the setup of EMERTEC, a new startup fund for investing in new high technology companies on emerging, booming markets. The shares issue has been open since January 2000 and has already raised 120 million francs out of the 160-million... view more... (2000-06-20)
Combination vaccine protects monkeys from ebola and Marburg viruses
An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys. view more (2008-02-27)
|
|
|
|
Sort By:
Page Views | Date |
|
